COVIDIG (COVID-19 Hyper-ImmunoGlobulin)
Clinical trial NCT04555148 · COMPLETED
Trial details
- NCT number
- NCT04555148
- Sponsor
- Green Cross Corporation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-19
- Primary completion
- 2021-01-22
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.